Tamoxifene (TAM) and primary breast cancer in old women (original) (raw)
The biological evaluation of novel antioestrogens for the treatment of breast cancer
Yunus Luqmani
Critical Reviews in Oncology/Hematology, 1993
View PDFchevron_right
Estrogenic effect of tamoxifen and its derivatives on the proliferation of MCF7 human breast tumor cells
CARLOS SONNENSCHEIN
Life Sciences, 1985
View PDFchevron_right
Tamoxifen binding sites heterogeneity in breast cancer: a comparative study with steroid hormone receptors
Santo Marsigliante, Palmiro Poltronieri
European Journal of Cancer and Clinical Oncology, 1991
View PDFchevron_right
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen
Todd Skaar
Cancer Chemotherapy and Pharmacology, 2005
View PDFchevron_right
Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen
David Zava
Cancer research, 1984
View PDFchevron_right
Estrogen receptor mediated and cytotoxic effects of the antiestrogen tamoxifen and 4-hydroxytamoxifen
David Zava
Cancer Research
View PDFchevron_right
Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the rat
Clive Dix
Molecular and Cellular Endocrinology, 1977
View PDFchevron_right
The role of tamoxifen and some bioactive compounds in resistance to the development of toxicity causing breast cancer in experimental animals
Dody Cat, Sift Desk Journals
Sift Desk Journals, 2018
View PDFchevron_right
New endocrine treatments for breast cancer: biological and clinical aspects
Anthony Howell
The Breast, 1996
View PDFchevron_right
Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other Diseases
Simak Ali
Annual Review of Medicine, 2011
View PDFchevron_right
International Congress on Hormonal Steroids and Hormones and Cancer New approaches to the understanding of tamoxifen action and resistance
Lev Berstein
View PDFchevron_right
The effect of cytotoxic drugs on estrogen receptor expression and response to Tamoxifen in MCF-7 cells (Cancer Res)
Robert Clarke
Cancer Res, 1986
View PDFchevron_right
Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients
Ernst Lien, Per Lønning
The Journal of steroid biochemistry and molecular biology, 1995
View PDFchevron_right
A New Antiestrogen, 2-(4-Hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), Inhibits the Growth of Tamoxifen-sensitive and -resistant Tumors and Is Devoid of Uterotropic Effects in Mice and Rats
Tami Annable
Clinical Cancer Research, 2001
View PDFchevron_right
Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice
Bernard Candas
Cancer research, 1998
View PDFchevron_right
Tamoxifen in advanced breast cancer
Torben Palshof
Cancer Treatment Reviews, 1978
View PDFchevron_right
Molecular Characterization of the Microsomal Tamoxifen Binding Site
M. Oulad-abdelghani
Journal of Biological Chemistry, 2004
View PDFchevron_right
Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver
Stefan Karlsson
Carcinogenesis, 1997
View PDFchevron_right
Influence of Antiestrogen Drugs on the Sex Hormone and Sex Hormone-Binding Globulin Levels in Breast Cancer Patients
Sandor Kerpel-Fronius
Annals of the New York Academy of Sciences, 1988
View PDFchevron_right
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells
Henri Rochefort
Cancer research, 1987
View PDFchevron_right
II.1 Tamoxifen's oestrogen-like effects in a breast cancer chemoprevention trial
Trevor Powles
European Journal of Cancer, 1998
View PDFchevron_right
Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens
Guy Leclercq
The Journal of Steroid Biochemistry and Molecular Biology, 2003
View PDFchevron_right
Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors
henrique gebrim
2006
View PDFchevron_right
Models of new antioestrogen action in vivo: primary tumours
Anthony Howell
The Breast, 1996
View PDFchevron_right
Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies
Fabio Leonessa
Cancer research, 1994
View PDFchevron_right
Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial
Aliana Guerrieri-Gonzaga
Clinical Cancer Research, 2004
View PDFchevron_right
Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in post-menopausal breast cancer patients (vol 52, pg 491, 1995)
Per Lønning
View PDFchevron_right
Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer
Karsten Parczyk
JNCI Journal of the National Cancer Institute, 2004
View PDFchevron_right
Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent
Guy Leclercq
Journal of Medicinal Chemistry, 1989
View PDFchevron_right